Delivery Order SPE2DX22D0049-SPE2D825FA9LL
- Not listed
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $47,608.56 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp is a...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $44,104.32 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was competitively awarded with no...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $2,074.02 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, represents a child contract under a larger indefinite delivery vehicle. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Department's Medical Supply Chain organization awarded a delivery order valued at $29,247.48 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999.9 million through December 2026. The award was competitively...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,840.50 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 28, 2025, with ultimate completion by July 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $19,611.57 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $26.1K to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 27, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The delivery...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,259.02 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 31, 2025, with an ultimate completion date of August 1, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $27,021.18 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. The contract will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $7,873.02 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D825FA9LLDelivery Order
The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $13,677.48 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a child contract with no set-aside designation, competitively awarded through open procurement. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (designated SPE2DX), a prime vendor agreement valued at $999,999,999.00 and extending through December 2026. This global pharmaceutical support vehicle enables the company to deliver brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical devices across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The company's consistent awards through open competition demonstrate its capability to meet rigorous federal medical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.7k | 7/28/25 |